Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model

Overview of attention for article published in Frontiers in endocrinology, December 2022

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age and source (61st percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 37 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 30,007 followers.

RT @Brunorm84: #Semaglutide ameliorates #metabolism and hepatic outcomes in an #NAFLD mouse model @FrontEndocrinol https://t.co/WQKqWBm6jg

10 Dec 2022

Reply Repost Favourite

#Semaglutide ameliorates #metabolism and hepatic outcomes in an #NAFLD mouse model @FrontEndocrinol https://t.co/WQKqWBm6jg

10 Dec 2022

Reply Repost Favourite

New Research: Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model: Purpose The aim of this study was to evaluate changes in body weight, liver weight, blood glucose, liver injury markers, pro-inflammatory… https://t.co/tNpWV1LN

09 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.